No Data
No Data
Veeva Systems -11% Q1 Earnings Beat Estimates, Margins Up
ResMed Inc. Publishes Conflict Minerals Report
2 ASX Healthcare Shares to Buy Now for the AI Revolution
If you're looking to capitalise on the artificial intelligence (AI) revolution, you might consider investing in ASX healthcare shares.
4 ASX Growth Shares to Buy to Supercharge Your Portfolio in June
Are you looking to add some growth shares to your investment portfolio in June?If you are, then the four highly rated ASX growth shares listed below could be worth considering.
2 No-brainer ASX 200 Shares to Buy Next Week
There are a lot of quality companies for investors to choose from on the Australian share market.
ResMed Shares Higher as Company 'Turns the GLP Threat Into an Opportunity': Fundie
ResMed CDI (ASX: RMD) shares closed at $32.80 apiece on Tuesday, up 1.14% for the day.
No Data